Andrew McKenzie, Vice President, Personalized Medicine at Sarah Cannon, shared a post on LinkedIn:
“As World Cancer Day approaches, I’ve taken time to reflect on how I see this year’s United by Unique theme in my work at Sarah Cannon Research Institute. Researchers everywhere are seeing how personalized cancer research is informing more individualized care.
By using genetic and molecular profiling to better understand tumor biology, we can generate insights that help guide clinical decisions across treatment planning and research participations.
Embedding personalized research capabilities within community-based care settings helps ensure molecular insight can inform decisions across the network. Our work at Sarah Cancer Research Institute helps bring those insights into everyday care settings across the network, supporting more informed and individualized decisions in the communities where people receive care.”
More posts featuring Sarah Cannon Research Institute.